Dr. Deborah Chirnomas Appointed to Lead Yale Pediatric Transplant Program
For Immediate Release
Date: 12/18/09
Contact: Renee Gaudette, (203) 436-8533, or renee.gaudette@yale.edu
New Haven, Conn. — Deborah Chirnomas, MD has been named an Assistant Professor of Pediatrics at Yale School of Medicine and Director of the planned Pediatric Bone Marrow Transplant Program at Smilow Cancer Hospital at Yale-New Haven. Dr. Chirnomas joins Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven from Children's Hospital Boston.
“Dr. Chirnomas is nationally recognized for her leadership in pediatric bone marrow transplantation. We are excited to have her expertise at Yale to benefit pediatric cancer patients who are in need of a transplant,” said Dr. Thomas J. Lynch, Jr., Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital at Yale-New Haven.
Dr. Chirnomas concentrates her clinical research on the impact and management of iron overload, a common side effect of stem cell transplantation. She is the national principal investigator on several clinical trials studying the control of iron overload in patients.
Previously, Dr. Chirnomas served as an Instructor at Harvard School of Medicine and an Attending Physician at Children’s Hospital Boston/Dana Farber Cancer Institute. She served as Chief Pediatric Resident at Yale-New Haven Hospital from 2001-2002. Dr. Chirnomas is a member of the American Academy of Pediatrics, American Society of Pediatric Hematology/Oncology, American Society for Bone and Marrow Transplantation, and American Society of Hematology.
A graduate of the University of Pennsylvania, Dr. Chirnomas received her medical degree from Albert Einstein College of Medicine of Yeshiva University. She earned a Masters of Public Health from Harvard School of Public Health. Dr. Chirnomas completed a fellowship in Pediatric Hematology/Oncology at Children’s Hospital Boston/Dana Farber Cancer Institute.
Yale Cancer Center is one of a select network of 40 comprehensive cancer centers in the country designated by the National Cancer Institute and the only one in Southern New England. Bringing together the resources of Yale-New Haven Hospital and the Yale University School of Medicine, its mission encompasses patient care, research, cancer prevention and control, community outreach and education.